Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 82   

Articles published

ARNA 4.47 -0.17 (-3.66%)
price chart
Fall in love with these 3 Biotech stocks - Arena Pharmaceuticals, Inc. (NASDAQ ...
Ms. Bielasz joined Arena in 2001 and is responsible for managing all accounting activities. Prior to joining Arena, Ms. Bielasz served as the controller of both public and private companies and began her career at KPMG LLP.
Healthcare Sector Update: KERX, IDRA, ARNA, CLDX  Wsnews4investors (press release) (blog)
Arena - Belviq Advertising Report For June (ARNA)
Arena (NASDAQ:ARNA) investors have had a tough second quarter. Script sales of the anti-obesity drug Belviq ... The company supplies data on ads aired, networks, spending, and even allow comparisons within a sector. Savvy investors can look at ad data ...
Momentum Stock in Focus - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
According to Zacks, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has been given a high momentum style score. The score calculation is based on a number of factors indicating that the stock might be at a favorable level to enter a position based on the ...
Company Shares of Arena Pharmaceuticals, Inc. Drops by -0.68%  Insider Trading Report
Healthcare Sector Movers: Halozyme Therapeutics, Inc. (HALO), Arena ...  WallStreet Scope
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Analyst Rating Update
Research firm Zacks has rated Arena Pharmaceuticals (NASDAQ:ARNA) and has ranked it at 3, indicating that for the short term the shares are a hold.
Arena Pharmaceuticals Inc. (ARNA) is Trading Higher on Unusual Volume for ...
Arena Pharmaceuticals Inc. (ARNA) experienced unusually high volume on Jun. 30, as the stock gained 7.91% to a closing price of $4.64.
Biotech Stocks with Optimistic Trend - Arena Pharmaceuticals, Inc. (NASDAQ ...
Mr. Hoffman is expected to remain in his current role at Arena until July 10, 2015. “Robert has been a valuable member of our management team and, on behalf of myself and the company, I thank him for his years of leadership and service to Arena,” said ...
Stock in Motion: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares opened the most recent trading session at 4.3300 and at the time of writing the last Bid was at 4.5472.
Stock Insights on Arena Pharmaceuticals Inc (NASDAQ:ARNA)
[PRNewswire] Arena Pharmaceuticals Inc (NASDAQ:ARNA)(TREND ANALYSIS) announced that Robert E. Hoffman, Senior Vice President, Finance and Chief Financial Officer, has decided to leave the company after nearly 18 years of service to pursue ...
3 Biotech Stocks Are Getting Crushed – Arena Pharmaceuticals, Inc. (NASDAQ ...  Wall Street Observer
Stocks Plunging - Arena Pharmaceuticals (ARNA), Paragon Offshore (PGN ...  Investor Wired
Investor Insights on Arena Pharmaceuticals Inc (NASDAQ:ARNA)
The time has come for a monthly report on television advertising for Belviq from Arena Pharmaceuticals (NASDAQ:ARNA).
Large Outflow of Money Witnessed in Arena Pharmaceuticals, Inc.  News Watch International
Arena Pharmaceuticals, Inc. Analyst Rating Update  OTC Outlook
Arena Pharmaceuticals, Inc. Short Interest Update
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has seen a shortfall of 260,771 shares or 0.8% in the short interest. The remaining shorts are 12.8% of the total floated shares.